Connect with us

Technology

Analog Devices Reports Fourth Quarter and Fiscal 2024 Financial Results

Published

on

Fourth quarter revenue of more than $2.4 billion, above the midpoint of guidance with sequential growth across all end marketsFiscal 2024 revenue of more than $9.4 billionFiscal 2024 operating cash flow of $3.9 billion and free cash flow of $3.1 billionReturned more than $2.4 billion to shareholders in fiscal 2024, including $0.6 billion of share repurchases and $1.8 billion of dividends

WILMINGTON, Mass., Nov. 26, 2024 /PRNewswire/ — Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, today announced financial results for its fiscal fourth quarter and fiscal year 2024, which ended November 2, 2024.

“ADI’s revenue, profitability, and earnings per share all finished above our guided midpoint, underscoring continued business momentum and solid execution,” said Vincent Roche, CEO and Chair.  “While unprecedented customer inventory headwinds drove a historic revenue decline during fiscal 2024, we maintained operating margins north of 40%, which is a testament to our business model’s resilience. We also continued to make strategic, long-term investments across engineering, manufacturing, and the end-to-end customer experience. As such, we enter 2025 as an even stronger enterprise, giving me the utmost confidence in our ability to drive increased value for customers and shareholders over the long term.”

“After a brief decline in overall bookings during our third quarter, orders picked up steadily throughout the fourth quarter, particularly in the Automotive end market. While macro uncertainty continues to limit the pace of our recovery, we remain cautiously optimistic for a strong growth year in fiscal 2025,” said Richard Puccio, CFO.

Performance for the Fourth Quarter and Fiscal Year 2024

Results Summary(1)

(in millions, except per-share amounts and percentages)

Three Months Ended

Twelve Months Ended

Nov. 2,
2024

Oct. 28,
2023

Change

Nov. 2,
2024

Oct. 28,
2023

Change

Revenue

$    2,443

$    2,716

(10) %

$    9,427

$  12,306

(23) %

Gross margin

$    1,416

$    1,647

(14) %

$    5,381

$    7,877

(32) %

Gross margin percentage

58.0 %

60.6 %

(260 bps)

57.1 %

64.0 %

(690 bps)

Operating income

$       569

$       634

(10) %

$    2,033

$    3,823

(47) %

Operating margin

23.3 %

23.4 %

(10 bps)

21.6 %

31.1 %

(950 bps)

Diluted earnings per share

$      0.96

$      1.00

(4) %

$      3.28

$      6.55

(50) %

Adjusted Results(2)

Adjusted gross margin

$    1,660

$    1,907

(13) %

$    6,404

$    8,925

(28) %

Adjusted gross margin percentage

67.9 %

70.2 %

(230 bps)

67.9 %

72.5 %

(460 bps)

Adjusted operating income

$    1,005

$    1,215

(17) %

$    3,853

$    6,014

(36) %

Adjusted operating margin

41.1 %

44.7 %

(360 bps)

40.9 %

48.9 %

(800 bps)

Adjusted diluted earnings per share

$      1.67

$      2.01

(17) %

$      6.38

$    10.09

(37) %

Three Months Ended

Trailing Twelve
Months

Cash Generation

Nov. 2, 2024

Nov. 2, 2024

Net cash provided by operating activities

$                          1,051

$                            3,853

% of revenue

43 %

41 %

Capital expenditures

$                            (165)

$                              (730)

Free cash flow(2)

$                             885

$                            3,122

% of revenue

36 %

33 %

Three Months Ended

Trailing Twelve
Months

Cash Return

Nov. 2, 2024

Nov. 2, 2024

Dividend paid

$                           (457)

$                          (1,795)

Stock repurchases

(95)

(616)

Total cash returned

$                           (552)

$                          (2,411)

(1) The sum and/or computation of the individual amounts may not equal the total due to rounding.

(2) Reconciliations of non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this press release.  See also the “Non-GAAP Financial Information” section for additional information.

 

Outlook for the First Quarter of Fiscal Year 2025

For the first quarter of fiscal 2025, we are forecasting revenue of $2.35 billion, +/- $100 million. At the midpoint of this revenue outlook, we expect reported operating margin of approximately 22.0%, +/- 130 bps, and adjusted operating margin of approximately 40.0%, +/- 100 bps. We are planning for reported EPS to be $0.80, +/- $0.10, and adjusted EPS to be $1.53, +/- $0.10.  

Our first quarter fiscal 2025 outlook is based on current expectations and actual results may differ materially as a result of, among other things, the important factors discussed at the end of this release. These statements supersede all prior statements regarding our business outlook set forth in prior ADI news releases, and ADI disclaims any obligation to update these forward-looking statements.

The adjusted results and adjusted anticipated results above are financial measures presented on a non-GAAP basis. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this release. See also the “Non-GAAP Financial Information” section for additional information.

Dividend Payment

The ADI Board of Directors has declared a quarterly cash dividend of $0.92 per outstanding share of common stock. The dividend will be paid on December 20, 2024 to all shareholders of record at the close of business on December 9, 2024.

Conference Call Scheduled for Today, Tuesday, November 26, 2024 at 10:00 am ET

ADI will host a conference call to discuss our fourth quarter and fiscal 2024 results and short-term outlook today, beginning at 10:00 am ET. Investors may join via webcast, accessible at investor.analog.com.

Non-GAAP Financial Information

This release includes non-GAAP financial measures that are not in accordance with, nor an alternative to, U.S. generally accepted accounting principles (GAAP) and may be different from non-GAAP measures presented by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. These non-GAAP measures have material limitations in that they do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP and should not be considered in isolation from, or as a substitute for, the Company’s financial results presented in accordance with GAAP. The Company’s use of non-GAAP measures, and the underlying methodology when including or excluding certain items, is not necessarily an indication of the results of operations that may be expected in the future, or that the Company will not, in fact, record such items in future periods. You are cautioned not to place undue reliance on these non-GAAP measures. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this release.

Management uses non-GAAP measures internally to evaluate the Company’s operating performance from continuing operations against past periods and to budget and allocate resources in future periods. These non-GAAP measures also assist management in evaluating the Company’s core business and trends across different reporting periods on a consistent basis. Management also uses these non-GAAP measures as primary performance measurements when communicating with analysts and investors regarding the Company’s earnings results and outlook and believes that the presentation of these non-GAAP measures is useful to investors because it provides investors with the operating results that management uses to manage the Company and enables investors and analysts to evaluate the Company’s core business. Management also believes that free cash flow, a non-GAAP liquidity measure, is useful both internally and to investors because it provides information about the amount of cash generated after capital expenditures that is then available to repay debt obligations, make investments and fund acquisitions, and for certain other activities. 

The non-GAAP financial measures referenced by ADI in this release include: adjusted gross margin, adjusted gross margin percentage, adjusted operating expenses, adjusted operating expenses percentage, adjusted operating income, adjusted operating margin, adjusted nonoperating expense (income), adjusted income before income taxes, adjusted provision for income taxes, adjusted tax rate, adjusted diluted earnings per share (EPS), free cash flow, and free cash flow revenue percentage.

Adjusted gross margin is defined as gross margin, determined in accordance with GAAP, excluding: certain acquisition related expenses1, which are described further below. Adjusted gross margin percentage represents adjusted gross margin divided by revenue.

Adjusted operating expenses is defined as operating expenses, determined in accordance with GAAP, excluding: certain acquisition related expenses1, acquisition related transaction costs2, and special charges, net3, which are described further below. Adjusted operating expenses percentage represents adjusted operating expenses divided by revenue.

Adjusted operating income is defined as operating income, determined in accordance with GAAP, excluding: acquisition related expenses1, acquisition related transaction costs2, and special charges, net3, which are described further below. Adjusted operating margin represents adjusted operating income divided by revenue.

Adjusted nonoperating expense (income) is defined as nonoperating expense (income), determined in accordance with GAAP, excluding: certain acquisition related expenses1, which is described further below.

Adjusted income before income taxes is defined as income before income taxes, determined in accordance with GAAP, excluding: acquisition related expenses1, acquisition related transaction costs2, and special charges, net3, which are described further below.

Adjusted provision for income taxes is defined as provision for income taxes, determined in accordance with GAAP, excluding tax related items4, which are described further below. Adjusted tax rate represents adjusted provision for income taxes divided by adjusted income before income taxes. 

Adjusted diluted EPS is defined as diluted EPS, determined in accordance with GAAP, excluding: acquisition related expenses1, acquisition related transaction costs2, special charges, net3, and tax related items4, which are described further below. 

Free cash flow is defined as net cash provided by operating activities, determined in accordance with GAAP, less additions to property, plant and equipment, net. Free cash flow revenue percentage represents free cash flow divided by revenue. 

1Acquisition Related Expenses: Expenses incurred as a result of current and prior period acquisitions and primarily include expenses associated with the fair value adjustments to debt, inventory, property, plant and equipment and amortization of acquisition related intangibles, which include acquired intangibles such as purchased technology and customer relationships. Expenses also include fair value adjustments associated with the replacement of share-based awards related to the Maxim Integrated Products, Inc. (Maxim) acquisition. We excluded these costs from our non-GAAP measures because they relate to specific transactions and are not reflective of our ongoing financial performance.

2Acquisition Related Transaction Costs: Costs directly related to the Maxim acquisition, including legal, accounting and other professional fees as well as integration-related costs. We excluded these costs from our non-GAAP measures because they relate to a specific transaction and are not reflective of our ongoing financial performance.

3Special Charges, net: Expenses, net, incurred as part of the integration of Maxim, in connection with facility closures, consolidation of manufacturing facilities, severance, other accelerated stock-based compensation expense and other cost reduction efforts or reorganizational initiatives. We excluded these expenses from our non-GAAP measures because apart from ongoing expense savings as a result of such items, these expenses have no direct correlation to the operation of our business in the future.

4Tax Related Items: Income tax effect of the non-GAAP items discussed above, an income tax benefit from a discrete tax item related to a federal corporate income tax relief claim and certain other income tax benefits associated with prior periods. We excluded the income tax effect of these tax related items from our non-GAAP measures because they are not associated with the tax expense on our current operating results.

About Analog Devices, Inc.

Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than $9 billion in FY24 and approximately 24,000 people globally, ADI ensures today’s innovators stay Ahead of What’s Possible. Learn more at www.analog.com and on LinkedIn and Twitter (X).

Forward Looking Statements

This press release contains forward-looking statements, which address a variety of subjects including, for example, our statements regarding our 2025 financial performance; expected revenue, operating margin, nonoperating expenses, tax rate, earnings per share, free cash flow returns, and other financial results; customer inventory rationalization; economic uncertainty, geopolitical conditions, demand, and other market conditions, business cycles, and supply chains; capital expenditures and investments, including those related to digital, software, cybersecurity, and artificial intelligence; expected market and technology trends; market size, market share gains, market position, and growth opportunities; our opportunity pipeline; expected product solutions, offerings, technologies, capabilities, and applications, including those that may incorporate, or be based upon, software or artificial intelligence technology; the value and importance of, and other benefits related to, our product solutions, offerings, and technologies to our customers, including those that may incorporate, or be based upon, software or artificial intelligence technology; our manufacturing capacity and investments to enhance resiliency; expected tax credits; future dividends and share repurchases; expected revenue synergies; and other future events. Statements that are not historical facts, including statements about our beliefs, plans and expectations, are forward-looking statements. Such statements are based on our current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: economic, political, legal and regulatory uncertainty or conflicts; changes in demand for semiconductor products; manufacturing delays, product and raw materials availability and supply chain disruptions; products that may be diverted from our authorized distribution channels; changes in export classifications, import and export regulations or duties and tariffs; our development of technologies and research and development investments; our future liquidity, capital needs and capital expenditures; our ability to compete successfully in the markets in which we operate; our ability to recruit and retain key personnel; risks related to acquisitions or other strategic transactions; security breaches or other cyber incidents; risks related to the use of artificial intelligence in our business operations, products, and services; adverse results in litigation matters; reputational damage; changes in our estimates of our expected tax rates based on current tax law; risks related to our indebtedness; the discretion of our Board of Directors to declare dividends and our ability to pay dividends in the future; factors impacting our ability to repurchase shares; and uncertainty as to the long-term value of our common stock. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the Securities and Exchange Commission, including the risk factors contained in our most recent Annual Report on Form 10-K. Forward-looking statements represent management’s current expectations and are inherently uncertain. Except as required by law, we do not undertake any obligation to update forward-looking statements made by us to reflect subsequent events or circumstances.

Analog Devices and the Analog Devices logo are registered trademarks or trademarks of Analog Devices, Inc. All other trademarks mentioned in this document are the property of their respective owners.

 

ANALOG DEVICES, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In thousands, except per share amounts)

Three Months Ended

Twelve Months Ended

Nov. 2, 2024

Oct. 28, 2023

Nov. 2, 2024

Oct. 28, 2023

Revenue

$      2,443,205

$      2,716,484

$      9,427,157

$   12,305,539

Cost of sales

1,027,077

1,069,768

4,045,814

4,428,321

Gross margin

1,416,128

1,646,716

5,381,343

7,877,218

Operating expenses:

   Research and development

378,903

406,594

1,487,863

1,660,194

   Selling, marketing, general and administrative

277,220

288,936

1,068,640

1,273,584

   Amortization of intangibles

187,754

202,736

754,784

959,618

   Special charges, net

2,859

114,035

37,258

160,710

Total operating expenses

846,736

1,012,301

3,348,545

4,054,106

Operating income

569,392

634,415

2,032,798

3,823,112

Nonoperating expense (income):

   Interest expense

82,804

71,590

322,227

264,641

   Interest income

(27,947)

(9,089)

(78,817)

(41,287)

   Other, net

(1,793)

128

12,048

(8,245)

Total nonoperating expense (income)

53,064

62,629

255,458

215,109

Income before income taxes

516,328

571,786

1,777,340

3,608,003

Provision for income taxes

38,256

73,356

142,067

293,424

Net income

$         478,072

$         498,430

$      1,635,273

$      3,314,579

Shares used to compute earnings per share – basic

496,432

497,073

496,166

502,232

Shares used to compute earnings per share – diluted

498,722

500,424

498,697

505,959

Basic earnings per common share

$                0.96

$                1.00

$                3.30

$                6.60

Diluted earnings per common share

$                0.96

$                1.00

$                3.28

$                6.55

 

ANALOG DEVICES, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

(thousands, except per share amounts)

Nov. 2, 2024

Oct. 28, 2023

ASSETS

Current Assets

Cash and cash equivalents

$          1,991,342

$             958,061

Short-term investments

371,822

Accounts receivable

1,336,331

1,469,734

Inventories

1,447,687

1,642,214

Prepaid expenses and other current assets

337,472

314,013

Total current assets

5,484,654

4,384,022

Other Assets

Net property, plant and equipment

3,415,550

3,219,157

Goodwill

26,909,775

26,913,134

Intangible assets, net

9,585,464

11,311,957

Deferred tax assets

2,083,752

2,223,272

Other assets

749,082

742,936

Total non-current assets

42,743,623

44,410,456

 TOTAL ASSETS

$        48,228,277

$        48,794,478

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current Liabilities

Accounts payable

$             487,457

$             493,041

Income taxes payable

447,379

309,046

Debt, current

399,636

499,052

Commercial paper notes

547,738

547,224

Accrued liabilities

1,106,070

1,352,608

Total current liabilities

2,988,280

3,200,971

Non-current Liabilities

Long-term debt

6,634,313

5,902,457

Deferred income taxes

2,624,392

3,127,852

Income taxes payable

260,486

417,076

Other non-current liabilities

544,489

581,000

Total non-current liabilities

10,063,680

10,028,385

Shareholders’ Equity

Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding

Common stock, $0.16 2/3 par value, 1,200,000,000 shares authorized, 496,296,854 shares outstanding (496,261,678 on October 28, 2023)

82,718

82,712

Capital in excess of par value

25,082,243

25,313,914

Retained earnings

10,196,612

10,356,798

Accumulated other comprehensive loss

(185,256)

(188,302)

Total shareholders’ equity

35,176,317

35,565,122

 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$        48,228,277

$        48,794,478

 

ANALOG DEVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

Three Months Ended

Twelve Months Ended

Nov. 2, 2024

Oct. 28, 2023

Nov. 2, 2024

Oct. 28, 2023

Cash flows from operating activities:

  Net income

$       478,072

$       498,430

$    1,635,273

$    3,314,579

  Adjustments to reconcile net income to net cash provided by operations:

       Depreciation

97,241

82,919

362,771

334,704

       Amortization of intangibles

423,220

453,198

1,741,545

1,958,399

       Stock-based compensation expense

70,448

72,710

262,710

299,823

       Deferred income taxes

(97,997)

(21,553)

(367,563)

(452,946)

       Other

(776)

(10,465)

23,050

8,665

       Changes in operating assets and liabilities

80,609

112,055

194,743

(645,590)

   Total adjustments

572,745

688,864

2,217,256

1,503,055

Net cash provided by operating activities

1,050,817

1,187,294

3,852,529

4,817,634

   Percent of revenue

43 %

44 %

41 %

39 %

Cash flows from investing activities:

  Purchases of short-term investments

(438,901)

  Maturities of short-term investments

69,279

69,279

  Additions to property, plant and equipment, net

(165,410)

(476,393)

(730,463)

(1,261,463)

  Other

(15,483)

(2,668)

(4,773)

(4,922)

Net cash used for investing activities

(111,614)

(479,061)

(1,104,858)

(1,266,385)

Cash flows from financing activities:

  Proceeds from debt

1,087,856

  Early termination of debt

(65,688)

  Debt repayments

(499,966)

(499,966)

  Proceeds from commercial paper notes

2,474,948

2,640,615

10,184,439

5,287,124

  Payments of commercial paper notes

(2,474,652)

(2,638,101)

(10,183,925)

(4,739,900)

  Dividend payments to shareholders

(456,756)

(427,974)

(1,795,459)

(1,679,106)

  Repurchase of common stock

(94,878)

(469,937)

(615,590)

(2,963,955)

  Proceeds from employee stock plans

4,860

5,606

121,215

118,608

  Other

(7,449)

(9,627)

(12,960)

(20,843)

Net cash used for financing activities

(1,053,893)

(899,418)

(1,714,390)

(4,063,760)

Net (decrease) increase in cash and cash equivalents

(114,690)

(191,185)

1,033,281

(512,511)

Cash and cash equivalents at beginning of period

2,106,032

1,149,246

$       958,061

$    1,470,572

Cash and cash equivalents at end of period

$    1,991,342

$       958,061

$    1,991,342

$       958,061

 

ANALOG DEVICES, INC.

REVENUE TRENDS BY END MARKET

(Unaudited)

(In thousands)

The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which our product will be incorporated. As data systems for capturing and tracking this data and our methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, we reclassify revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market.

Three Months Ended

Nov. 2, 2024

Oct. 28, 2023

Revenue

% of revenue*

Y/Y %

Revenue

% of revenue*

Industrial

$          1,070,978

44 %

(21) %

$          1,356,884

50 %

Automotive

716,964

29 %

(2) %

733,014

27 %

Communications

275,573

11 %

(18) %

336,238

12 %

Consumer

379,690

16 %

31 %

290,348

11 %

Total revenue

$          2,443,205

100 %

(10) %

$          2,716,484

100 %

Twelve Months Ended

Nov. 2, 2024

Oct. 28, 2023

Revenue

% of revenue*

Y/Y %

Revenue

% of revenue*

Industrial

$          4,314,280

46 %

(35) %

$          6,611,794

54 %

Automotive

2,827,439

30 %

(2) %

2,876,140

23 %

Communications

1,080,496

11 %

(33) %

1,606,426

13 %

Consumer

1,204,942

13 %

(1) %

1,211,179

10 %

Total revenue

$          9,427,157

100 %

(23) %

$        12,305,539

100 %

*The sum of the individual percentages may not equal the total due to rounding.

 

ANALOG DEVICES, INC.

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(Unaudited)

(In thousands, except per share amounts)

Three Months Ended

Twelve Months Ended

Nov. 2, 2024

Oct. 28, 2023

Nov. 2, 2024

Oct. 28, 2023

Gross margin

$       1,416,128

$       1,646,716

$       5,381,343

$       7,877,218

  Gross margin percentage

58.0 %

60.6 %

57.1 %

64.0 %

      Acquisition related expenses

243,667

259,925

1,022,488

1,047,309

Adjusted gross margin

$       1,659,795

$       1,906,641

$       6,403,831

$       8,924,527

  Adjusted gross margin percentage

67.9 %

70.2 %

67.9 %

72.5 %

Operating expenses

$          846,736

$       1,012,301

$       3,348,545

$       4,054,106

  Percent of revenue

34.7 %

37.3 %

35.5 %

32.9 %

      Acquisition related expenses

(188,821)

(206,151)

(760,325)

(976,223)

      Acquisition related transaction costs

(7,069)

      Special charges, net

(2,859)

(114,035)

(37,258)

(160,710)

Adjusted operating expenses

$          655,056

$          692,115

$       2,550,962

$       2,910,104

  Adjusted operating expenses percentage

26.8 %

25.5 %

27.1 %

23.6 %

Operating income

$          569,392

$          634,415

$       2,032,798

$       3,823,112

  Operating margin

23.3 %

23.4 %

21.6 %

31.1 %

      Acquisition related expenses

432,488

466,076

1,782,813

2,023,532

      Acquisition related transaction costs

7,069

      Special charges, net

2,859

114,035

37,258

160,710

Adjusted operating income

$       1,004,739

$       1,214,526

$       3,852,869

$       6,014,423

  Adjusted operating margin

41.1 %

44.7 %

40.9 %

48.9 %

Nonoperating expense (income)

$            53,064

$            62,629

$          255,458

$          215,109

      Acquisition related expenses

2,150

2,150

8,600

13,743

Adjusted nonoperating expense (income)

$            55,214

$            64,779

264,058

$          228,852

Income before income taxes

$          516,328

$          571,786

$       1,777,340

$       3,608,003

      Acquisition related expenses

430,338

463,926

1,774,213

2,009,789

      Acquisition related transaction costs

7,069

      Special charges, net

2,859

114,035

37,258

160,710

Adjusted income before income taxes

$          949,525

$       1,149,747

$       3,588,811

$       5,785,571

Provision for income taxes

$            38,256

$            73,356

$          142,067

$          293,424

  Effective tax rate

7.4 %

12.8 %

8.0 %

8.1 %

      Tax related items

76,702

70,503

265,697

388,093

Adjusted provision for income taxes

$          114,958

$          143,859

$          407,764

$          681,517

  Adjusted tax rate

12.1 %

12.5 %

11.4 %

11.8 %

Diluted EPS

$                 0.96

$                 1.00

$                 3.28

$                 6.55

      Acquisition related expenses

0.86

0.93

3.56

3.97

      Acquisition related transaction costs

0.01

      Special charges, net

0.01

0.23

0.07

0.32

      Tax related items

(0.15)

(0.14)

(0.53)

(0.77)

Adjusted diluted EPS*

$                 1.67

$                 2.01

$                 6.38

$               10.09

* The sum of the individual per share amounts may not equal the total due to rounding.

 

ANALOG DEVICES, INC.

RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW

(Unaudited)

(In thousands)

Trailing
Twelve
Months

Three Months Ended

Nov. 2, 2024

Nov. 2, 2024

Aug. 3, 2024

May. 4, 2024

Feb. 3, 2024

Revenue

$   9,427,157

$ 2,443,205

$ 2,312,209

$    2,159,039

$ 2,512,704

Net cash provided by operating activities

$   3,852,529

$ 1,050,817

$    855,027

$       807,853

$ 1,138,832

% of Revenue

41 %

43 %

37 %

37 %

45 %

Capital expenditures

$     (730,463)

$   (165,410)

$   (153,886)

$      (188,189)

$   (222,978)

Free cash flow

$   3,122,066

$    885,407

$    701,141

$       619,664

$    915,854

% of Revenue

33 %

36 %

30 %

29 %

36 %

 

ANALOG DEVICES, INC.

RECONCILIATION OF PROJECTED GAAP TO NON-GAAP RESULTS

(Unaudited)

Three Months Ending February 1, 2025

Reported

Adjusted

Revenue

$2.35 Billion

$2.35 Billion

(+/- $100 Million)

(+/- $100 Million)

Operating margin

22.0 %

40.0 %(1)

(+/-130 bps)

(+/-100 bps)

Nonoperating expenses

~ $60 Million

~ $60 Million

Tax rate

12% – 14%

12% – 14% (2)

Earnings per share

$0.80

$1.53 (3)

(+/- $0.10)

(+/- $0.10)

(1) Includes $424 million of adjustments related to acquisition related expenses, as defined in the Non-GAAP Financial Information section of this press release. 

(2) Includes $55 million of tax effects associated with the adjustments for acquisition related expenses noted above.

(3) Includes $0.73 of adjustments related to the net impact of acquisition related expenses and the tax effects on those items.

 

For more information, please contact:

Investor Contact:
Analog Devices, Inc.
Mr. Michael Lucarelli
Vice President, Investor Relations and FP&A
781-461-3282
investor.relations@analog.com 

Media Contacts:
Analog Devices, Inc.
Ms. Ferda Millan
Global PR & External Communications
Ferda.Millan@analog.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/analog-devices-reports-fourth-quarter-and-fiscal-2024-financial-results-302315997.html

SOURCE Analog Devices, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple

Published

on

By

The article explains how sterile compounded medications are prepared to reduce the risk of contamination and support safe, customized treatments.

AZLE, Texas, July 21, 2026 /PRNewswire/ — What does sterile compounding mean for medication safety? HelloNation has published an article explaining how sterile compounding helps pharmacies prepare highly specialized medications while adhering to strict contamination-prevention procedures.

The article features insights from Laura Temple, Compounding Pharmacist Expert and Owner of Laura’s Pharmacy in Azle, Texas. It explains that sterile compounding is a specialized process for preparing medications in carefully controlled environments designed to reduce the risk of contamination. Sterile compounded medications are often used for injections, eye drops, IV medications, and other therapies that require the highest levels of cleanliness and precision.

The HelloNation article explains that sterile compounded medications differ from commercially manufactured drugs because they are prepared individually for a patient’s unique medical needs. Physicians may prescribe compounded prescriptions when a patient requires a customized dosage, a combination medication, or a treatment not commercially available. Because these medications often bypass the body’s natural defenses, medication safety depends on strict preparation standards throughout the compounding process.

The article describes how pharmacies that provide sterile compounding rely on cleanroom environments equipped with filtered-air systems, specialized equipment, and contamination-prevention protocols. Pharmacists and technicians follow detailed gowning, sterilization, and handwashing procedures before handling medication ingredients. These measures are designed to support medication safety by limiting exposure to bacteria, particles, and other contaminants.

According to the article, environmental monitoring also plays a critical role in sterile compounding. Temperature control, air quality testing, and routine equipment inspections help maintain consistent preparation standards. The article notes that sterile compounded medications may undergo additional quality assurance checks before being dispensed to patients. These procedures help support both treatment effectiveness and patient safety.

The HelloNation article also explains that pharmacies performing sterile compounding are expected to follow USP guidelines established for sterile preparation. These USP guidelines outline requirements for cleanroom pharmacy operations, environmental testing, employee training, and quality assurance practices. The article emphasizes that maintaining compliance with USP guidelines helps reinforce contamination prevention and consistent preparation standards for compounded prescriptions.

Patients seeking sterile compounded medications may also look for pharmacies that participate in accreditation programs or are overseen by state boards. The article explains that these programs review safety procedures, documentation practices, and facility standards to help maintain medication safety. Regular environmental monitoring and staff competency evaluations are also identified as important safeguards in sterile compounding operations.

The article further explains that communication between pharmacists, healthcare providers, and patients remains an important part of safe compounded prescriptions. Compounding pharmacists review prescriptions carefully, confirm dosing instructions, and evaluate ingredient compatibility before preparation begins. This collaborative approach supports medication safety by reducing the risk of errors and ensuring treatments meet individual patient needs.

The article concludes that sterile compounding continues to play an important role in healthcare, particularly for patients requiring customized therapies that are unavailable through traditional manufacturing channels. Whether preparing IV medications, injectable therapies, or other sterile compounded medications, pharmacies rely on contamination prevention procedures and strict preparation standards to support patient care. The article notes that understanding how sterile compounding works can help patients feel more informed about the safety measures involved in preparing specialized medications.

What Sterile Compounding Means for Medication Safety features insights from Laura Temple, a compounding pharmacist expert at Laura’s Pharmacy in Azle, Texas, on HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-highlights-sterile-compounding-and-medication-safety-with-insights-from-compounding-pharmacist-expert-laura-temple-302831275.html

SOURCE HelloNation

Continue Reading

Technology

CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group

Published

on

By

Regulatory demands are increasing in volume, complexity, and speed, leaving many organizations reliant on fragmented, manual approaches that slow response times and increase risk. New insights from Info-Tech Research Group show that organizations need to adopt more structured and scalable approaches to keep pace with regulatory change. The firm’s recently published blueprint, Build a Regulatory IT Response Engine, provides frameworks, tools, and step-by-step guidance to help organizations translate regulatory requirements into actionable IT controls and prioritized initiatives.

ARLINGTON, Va., July 21, 2026 /PRNewswire/ — Growing regulatory pressure across jurisdictions is forcing organizations to rethink how they interpret, prioritize, and execute compliance requirements. Many IT teams continue to operate with inconsistent processes and limited coordination, resulting in delayed initiatives and increased exposure to financial and reputational risk. Info-Tech’s blueprint, Build a Regulatory IT Response Engine, introduces a coordinated and repeatable approach to help IT leaders operationalize compliance and improve execution outcomes.

Info-Tech’s findings indicate that while organizations recognize the need for faster and more consistent regulatory response, they continue to face barriers such as fragmented interpretation of requirements, weak prioritization, and limited scalability. AI-enabled tools can help streamline analysis and accelerate response planning, but without a coordinated approach grounded in governance and human oversight, those benefits are difficult to realize.

“Regulatory response is becoming too complex to manage through disconnected, manual processes,” says Ahmad Jowhar, senior research analyst at Info-Tech Research Group. “IT leaders need a repeatable way to interpret requirements, prioritize action, and use AI to accelerate planning without losing the governance and oversight needed to execute effectively.”

Key Challenges IT Leaders Face in Regulatory Response

Despite ongoing investments in compliance, organizations continue to face systemic challenges that hinder effective execution. Info-Tech’s blueprint highlights several areas where IT and compliance leaders struggle most:

Fragmented and manual processes that slow regulatory interpretation and response.Inconsistent application of regulatory requirements across teams and jurisdictions.Poor prioritization of IT initiatives, leading to missed deadlines and duplicated effort.Limited scalability to manage increasing regulatory volume and complexity.Misalignment between compliance activities and broader business priorities.

Info-Tech’s Framework for Building a Regulatory IT Response Engine

To address these challenges, Info-Tech recommends a structured, AI-enabled approach that improves consistency, speed, and scalability. The firm’s Build a Regulatory IT Response Engine blueprint outlines the following key priorities for IT leaders:

Define the regulatory landscape: Establish organizational context, governance structures, and a centralized inventory of applicable regulations.Translate requirements into IT controls: Use AI-enabled analysis and structured assessments to convert regulatory obligations into actionable controls.Prioritize IT initiatives: Align initiatives based on cost, effort, impact, and regulatory timelines to reduce execution risk.Build and communicate a roadmap: Develop a clear, resource-aligned roadmap to guide execution and stakeholder alignment.Establish a repeatable process: Continuously monitor, adapt, and refine regulatory response capabilities to maintain compliance over time.

Organizations that adopt this structured approach can move from reactive compliance efforts to a more proactive and scalable model that shortens response timelines, reduces manual effort, and strengthens execution.

The firm’s Build a Regulatory IT Response Engine blueprint includes practical tools such as a Regulation Inventory Tool, a Regulatory Response IT Action Plan Tool, a Communication Deck Template, and a Compliance Program Framework. By applying these resources, IT leaders can standardize regulatory responses, improve prioritization, and help ensure compliance initiatives are executed on time and in alignment with business priorities.

For exclusive and timely commentary from Info-Tech’s experts, including Ahmad Jowhar, and access to the complete Build a Regulatory IT Response Engine blueprint, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.

To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.

Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cios-forced-to-rethink-manual-compliance-processes-as-regulatory-complexity-rises-says-info-tech-research-group-302831286.html

SOURCE Info-Tech Research Group

Continue Reading

Technology

Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026

Published

on

By

LOS GATOS, Calif., July 21, 2026 /PRNewswire/ — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its second quarter 2026 financial results after the market closes on Tuesday, Aug. 4, 2026.

The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, Aug. 4, 2026, to discuss the results. The live webinar can be accessed through Atomera’s investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. To pre-register for the webinar, use the following link.

https://atomera.zoom.us/webinar/register/WN_OJFbTWe1SIyV69LLdDadCw

About Atomera

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-to-announce-second-quarter-2026-financial-results-and-host-webinar-on-tuesday-august-4-2026-302830602.html

SOURCE Atomera Incorporated

Continue Reading

Trending